Press Release Archive - 2012

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

16 Jan 2012

Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. LTD.
READ  

27 Feb 2012

Antares Pharma Appoints John J. Howarth Vice President of Corporate Affairs
READ  

29 Feb 2012

Antares Pharma to Present at Upcoming Investor Conferences Cowen and Roth
READ  

05 Mar 2012

Antares Pharma to host 4th Quarter Earnings Call
READ  

12 Mar 2012

Antares Pharma Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
READ  

28 Mar 2012

Antares Pharma To Present At The 11th Annual Needham Healthcare Conference
READ  

26 Apr 2012

Watson Launches Gelnique 3%
READ  

26 Apr 2012

Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva and Pfizer
READ  

01 May 2012

Antares Pharma Announces Q1 2012 Earnings
READ  

08 May 2012

Antares Q1 2012 Earnings Results
READ  

10 May 2012

Antares Pharma to Present at the 15th Annual Bank of America Merrill Lynch Health Care Conference
READ  

15 May 2012

Antares Pharma appoints LeRoux Jooste Senior Vice President of Pharmaceutical Sales and Marketing
READ  

31 May 2012

Antares Pharma to Present at the Jefferies Global Healthcare Conference
READ  

06 Jun 2012

Antares Pharma Announces Move to the Nasdaq Stock Market Company's Ticker Symbol Will Change to "ATRS"
READ  

26 Jun 2012

Antares Pharma Announces Positive Results From VIBEX MTX Usability Study
READ  

02 Jul 2012

Antares Pharma Appoints Jonathan S. Jaffe M.D. Vice President of Clinical Development
READ  

01 Aug 2012

Antares Pharma to Host Second Quarter 2012 Earnings Call
READ  

08 Aug 2012

Antares Pharma Reports Second Quarter 2012 Financial and Operating Results
READ  

30 Aug 2012

Antares Pharma To Present At The Stifel Nicolaus 2012 Healthcare Conference
READ  

25 Sep 2012

Antares Pharma Announces Successful Results From Vibex MTX Actual Human Use Study
READ  

02 Oct 2012

Antares Pharma Receives Developmental Milestone Payment
READ  

02 Oct 2012

Antares Pharma Announces Proposed Public Offering of Common Stock
READ  

03 Oct 2012

Antares Pharma Announces Pricing of Public Offering of Common Stock
READ  

09 Oct 2012

Antares Pharma Announces Closing of Public Offering of Common Stock
READ  

02 Nov 2012

Antares Pharma to Host Third Quarter 2012 Earnings Call
READ  

07 Nov 2012

Antares Q3 2012 Earnings Results
READ  

08 Nov 2012

Antares Pharma to Present at 2012 Jefferies Global Healthcare Conference
READ  

13 Nov 2012

Antares Pharma Announces Positive Results from Final MTX Medi-Jet Clinical Study
READ  

05 Dec 2012

Antares Pharma to Present at Oppenheimer 23rd Annual Healthcare Conference
READ  

17 Dec 2012

Antares Pharma Announces Submission of New Drug Application for OTREXUP
READ